ALT logo

ALT

Altimmune, Inc.NASDAQHealthcare
$3.34+7.05%ClosedMarket Cap: $294.8M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-16HC Wainwright & Co.Buy
2026-03-06B. Riley SecuritiesBuy
2025-11-07CitizensMarket Outperform
2025-10-20HC Wainwright & Co.Buy
2025-08-13UBSBuy
2025-08-13HC Wainwright & Co.Buy
2025-08-13B. Riley SecuritiesBuy
2025-07-10JMP SecuritiesMarket Outperform
2025-06-27HC Wainwright & Co.Buy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.18$25.7M7
Sun Dec 31$-0.53$94.1M7
Mon Dec 31$-0.06$265.8M2
Tue Dec 31$0.55$469.6M5
ALT | Altimmune, Inc. Analyst Ratings & Price Target - InvestLog